Chain Drug Review - Wellbutrin approval
March 17, 2008 -- Biovail Corp. has received Canadian clearance for Wellbutrin XL. The drug is for preventing major depressive illness...
Chain Drug Review - Wellbutrin dispute
March 19, 2007 -- Watson Pharmaceuticals Inc. will receive $35 million from GlaxoSmithKline PLC to settle litigation related to Wellbutrin XR, the latter's...
Chain Drug Review - Generic Wellbutrin to get review
October 27, 2008 -- The Food and Drug Administration says it is ready to conduct a human trial to resolve complaints concerning genetic Wellbutrin XL just months after...
Internal Medicine News - Wellbutrin XL
July 15, 2006 -- Wellbutrin XL (bupropion extended release, GlaxoSmithKline) An antidepressant for preventing seasonal major depressive episodes in people with...
Clinical Psychiatry News - FDA clears generic Wellbutrin
May 1, 2008 -- The generic formulation of Wellbutrin XL (300 mg) is bioequivalent to the brand, the Food and Drug Administration has determined. The agency began a...
M2 Presswire - Biovail Corp and Wellbutrin In Review.
January 17, 2007 -- M2 PRESSWIRE-17 January 2007-Pinnacle Digest: Biovail Corp and Wellbutrin In Review(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:17012007 Biovail...
Skin & Allergy News - Cubicin, Wellbutrin XL
August 1, 2006 -- Cubicin (daptomycin for injection, Cubist Pharmaceuticals) A cyclic lipopeptide antibiotic--a new antibiotic class--approved for treating patients...
Business Wire - Teva Announces Launch of Generic Wellbutrin XL® Tablets, 150 mg
May 30, 2008 -- JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has begun commercially shipping Bupropion...
Business Wire - Wellbutrin XR® Receives First European Approval
January 16, 2007 -- Marketing License Granted in The Netherlands for Adult Patients with Depression TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) marketing...
Market Wire - Actavis receives approval of generic Wellbutrin XL(R) 300mg in the United States
August 19, 2008 -- Reykjavik, Iceland, 19 August 2008 -- Actavis Group, the international generic pharmaceuticals company, todayannounced thatit has received approval...
